Ai Ling Wang

About Ai Ling Wang

Physician-scientist with a PhD in Ophthalmology and extensive experience in NGS-based variant interpretation, tumor/germline sequencing, and clinical genomics across CLIA/CAP-accredited laboratories.Board-certified Clinical Chemist (NRCC) with prior New Jersey Clinical Laboratory Director licensure. Skilled in ACMG/AMP variant classification, HGVS nomenclature, IGV review, and supporting directors in clinical reporting, assay validation, QC/QA, and SOP development.My work spans major academic medical centers, including Brigham and Women’s Hospital and Mount Sinai/Sema4, where I have interpreted complex genomic variants, optimized workflows, and trained MD/PhD fellows, residents, and clinical variant curators.I am passionate about bridging clinical medicine and molecular diagnostics, and I am actively pursuing pathways to resume Clinical Laboratory Director licensure in the U.S.

Experience

1. Senior Scientist

   Mass General Brigham

   Mar 2023 — Present · Boston, MA, US

   Leading variant interpretation for tumor/germline matched sequencing and NIPS-Perform ACMG/AMP classification and IGV review for complex variants-Support directors in reporting, workflow optimization, and assay validation-Train MD/PhD residents and fellows-Collaborate with bioinformatics and clinical teams to improve genomic workflows

Education

• Shandong Medical College

  Clinical Medicine

  1992 — 1995

• Weifang Medical College

  MSc, Ophthalmology

  1999 — 2002

• Peking University

  PhD, Ophthalmology

  2002 — 2005

Skills

• Genetics
• Histology
• Life Sciences
• Signal Transduction
• Biotechnology
• Treatment
• In Vitro
• Cell
• Clinical Trials
• Clinical Research
• Research
• Assay Development
• Pcr
• Next Generation Sequencing
• Laboratory
• Drug Development
• Cancer
• Cell Culture
• Protein Chemistry
• Ophthalmology
• Biomarker Discovery
• Animal Models
• Molecular Biology
• Proposal Writing
• Clinical Development
• Literature Reviews
• Qpcr
• Vaccines
• Biochemistry